Certified by Founder Lodge
Trinity Innovation Fund
China - Beijing
INVESTOR
1 Disclosed Funding Rounds $38,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 2018, Trinity Innovation Fund (TIF) is dedicated to investing on biomedical innovations. Currently we are managing two funds with different focuses. Our limited partners (LPs) incl
| Company | Date | Round | Raised |
|---|---|---|---|
 Adcentrx Therapeutics |
April, 25 ,2023 | Series A | $38,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
